no comments

Raising Awareness of Ovarian Cancer

Today is Teal Ribbon Day, raising awareness of ovarian cancer, showing support for the women and their families living with the disease, and remembering those who have died.

Member for Grey Rowan Ramsey is using the event to bring to light recent Government commitments to find a cure for this often fatal disease.

1,500 Australian women are likely to be diagnosed with ovarian cancer in 2017, with the survival rate less than 50% according to Mr Ramsey.

“It is these tough statistics that has seen a commitment by the Coalition Government to improve not just awareness, but treatment outcomes and drug availability.

“Teal Ribbon Day is an opportunity to remind ourselves of the tragedy of Ovarian and Gynaecological Cancers – not just for the women who are affected by them, but for their families and friends,” he said.

Mr Ramsey highlighted the Coalition’s commitment to finding a cure, noting Health Minister Greg’s Hunt recent announcement of $107 million to go towards ovarian cancer research.

“Facing ovarian cancer is a tough battle and there are so many women fighting that fight with courage and determination.

“For these women and those who may be diagnosed in the future it is imperative that we do all we can to find a cure.

“I am pleased Minister Hunt also recently listed Olaparib on the Pharmaceutical Benefits Scheme,” he said.

Olaparib is used in the treatment of high grade serious ovarian, fallopian, and peritoneal cancers and works by programming the destruction of cancerous cells.

Mr Ramsey highlighted the significantly lower cost of the drug, noting that approximately 237 Australian women will benefit from the scheme.

“What would otherwise have been more than $100,000 a year, will now be available for $38.80 per script or $6.30 per script for Health Card holders.”

Mr Ramsey said that because there is no early detection for Ovarian Cancer, women are very often diagnosed at an advanced stage, when it’s very difficult to treat.

“We are committed to raise awareness of ovarian cancer to accelerate early diagnosis and ensure that no woman with ovarian cancer walks alone.”

Image Source – Myriad Genetics